Riemser Arzneimittel AG · Class II · Cleared May 3, 2013
| K-number | K113539 |
| Device name | REVOIS PRO IMPLANT STSYEM |
| Applicant | Riemser Arzneimittel AG |
| Product code | DZE |
| Device class | Class II |
| Decision date | May 3, 2013 |
| Decision | Substantially Equivalent |
| Regulation | 872.3640 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov